Protective Effect of Proanthocyanidin against Diabetic Oxidative Stress
- 문서 유형
- 연구출판물 · 리뷰논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 피인용
- Web of Science 41
- JCR IF
- JCR 2011 4.774
- ISSN
- 1741-427X
저자
- Yokozawa, Takako제1저자
- 조은주부산대학교, 생활과학대학, 식품영양학과, KO
- HumPark, ChanToyama Univ, JA
- Kim, Ji HyunToyama Univ, JA
초록
We investigated the antidiabetic potential of proanthocyanidin and its oligomeric form in STZ-induced diabetic model rats and db/db type 2 diabetic mice. Proanthocyanidin ameliorated the diabetic condition by significant decreases of serum glucose, glycosylated protein, and serum urea nitrogen as well as decreases of urinary protein and renal-AGE in STZ-induced diabetic rats and decrease of serum glucose as well as significant decrease of glycosylated protein in db/db type 2 diabetic mice. The suppression of ROS generation and elevation of the GSH/GSSG ratio were also observed in the groups administered proanthocyanidin. Moreover, proanthocyanidin, especially its oligomeric form, affected the inflammatory process with the regulation of related protein expression, iNOS, COX-2 and upstream regulators, NF-kappa B, and the I kappa B-alpha. In addition, it had a marked effect on hyperlipidemia through lowering significant levels of triglycerides, total cholesterol, and NEFA. Moreover, expressions in the liver of SREBP-1 and SREBP-2 were downregulated by the administration of proanthocyanidins. The protective effect against hyperglycemia and hyperlipidemia in type 1 and 2 diabetic models was significantly strong in the groups administered the oligomeric rather than polymeric form. This suggests that oligomers act as a regulator in inflammatory reactions caused by oxidative stress in diabetes.
키워드
ELEMENT-BINDING PROTEIN-1ACTIVATED SIGNALING PATHWAYSKAPPA-B ACTIVATIONINSULIN-RESISTANCELIPID-PEROXIDATIONANTIOXIDANT STATUSRATSSUPPRESSIONEXPRESSIONMICE
식별자
- WoS UID
- 000296817800001



로그인
연구물 목록으로